Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Paul-Ehrlich-Institut shared a post on LinkedIn:
“Blood, blood products and stem cell preparations are indispensable for the treatment of many diseases and injuries. Their production relies on the help of numerous voluntary donors. It is therefore important to monitor the supply situation for blood and blood products in Germany so that measures can be taken to promote blood and plasma donation when shortages become apparent.
Every year, the Paul-Ehrlich-Institut collects data from donation centres, manufacturers and healthcare facilities in order to obtain a comprehensive overview of the supply of blood, blood products and stem cell preparations in Germany. The supply situation for 2024 is presented in the report that has now been published.
Read the full report here.”
Follow the latest in Hemostasis Today.
-
May 30, 2026, 10:36Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products